Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well a...Show More
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:OXB
localegb
websitehttps://oxb.com/
ipo_date1996-12-13
primary_stock_msh_idLSE:OXB
source_refbe9c727c-0823-4e84-bb7c-f1223925668c
products_or_servicesDevelopment and manufacture of viral vectors including lentivirus, adeno-associated virus (AAV), and adenovirus, as well as associated regulatory and analytical services.